← All trials
NCT04115072
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 3, 2019
- Primary completion
- Mar 1, 2020
- Completion date
- Mar 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 116
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Vendsyssel HospitalLead sponsor
- Merck SeronoCollaborator
- Government of MadagascarCollaborator
- Umea UniversityCollaborator
- Leiden UniversityCollaborator
- Humboldt UniversityCollaborator
- University of NagasakiCollaborator
- K'Ola VanonaOverall official - principal investigator
- Aalborg UniversityStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.